عبدالمجید صاحب سالک
پنجاب میں مولانا ظفر علی خاں مرحوم کے بعد ادب و صحافت کے میدان میں سب سے ممتاز اور رنگارنگ شخصیت عبدالمجید صاحب سالک مرحوم کی تھی، وہ ادیب و شاعر بھی تھے اور صحافی و مزاح نگار بھی، ان کا مذاق بڑا ستھرا اور قلم متوازن تھا، ایک زمانہ میں ان کی ذات لاہور کی ادبی سرگرمیوں کا مرکز تھی، پنجاب کے بہت سے نوجوان ادیب و صحافی ان ہی کے دامن تربیت کے پروردہ ہیں، طبعاً بڑے باغ و بہار، سخن طراز اور بزم آرا تھے، انھوں نے علم و ادب کے ساتھ ملک و ملت کی بھی خدمت انجام دی، متعدد علمی و ادبی تصانیف ان کی یادگار ہیں، ان میں ’’مسلم ثقافت ہندوستان میں‘‘ ان کے حسن مذاق کا نمونہ ہے، ابھی تھوڑے دن ہوئے ’’ہم نہیں ہوں گے‘‘ کی ردیف و قافیہ میں ان کی ایک بڑی دلکش نظم نظر سے گذری تھی، کیا معلوم تھا کہ یہ شاعری اتنی جلد واقعہ کی شکل اختیار کرلے گی، علم و ادب کی محفلوں میں مدتوں ان کی یاد آتی رہے گی، اﷲ تعالیٰ علم و ادب کے اس خادم کو اپنی رحمت و مغفرت سے سرفراز فرمائے۔
(شاہ معین الدین ندوی،نومبر ۱۹۵۹ء)
Liver plays an important role in lipid metabolism and any acute or chronic malfunction of the liver due to viral hepatitis or liver cirrhosis may induce lipid derangements Objective: To determine the patterns of deranged lipid profiles in patients of chronic hepatitis C Methods: It is a prospective, observational study, conducted at Medicine Department, Mayo Hospital Lahore for 6 months i.e.1stJanuary to 30th June 2018. After the ethical approval, 160 diagnosed cases of chronic hepatitis C of ages 18-70 years of either gender were selected by non-probability purposive sampling. Informed written consent was taken. Demographic information such as name, age and gender were recorded. Venous blood samples from patients after 10 to 14 hours of fasting were drawn for lipid profiles and sent to pathology laboratory. All results were expressed as mg/dl. Data were analyzed in SPSS version 22 Results: Out of 160 patients in this study, there were 94 males and 66 females. Total cholesterol was lower in 62.5% patients, normal in 33.75% patients and higher in 3.75% patients. Triglycerides levels were low in 66.25%, normal in 33.125%, and high in 0.625% patients. Low density lipoprotein (LDL) levels were low in 82.5% patients, normal in 10% and raised in 7.5% patients. High density lipoprotein (HDL) levels were low in 95%, normal in 4.375% & high in 0.625% patients Conclusions: Low levels of serum lipids including total cholesterol, triglycerides, LDL and HDL are seen in population suffering from chronic HCV infection.
Background: Non-Communicable Diseases (NCDs) are fast becoming the leading causes of morbidity and mortality in Low and Middle-income countries (LMIC) with cancers and cardiovascular diseases (CVDs) becoming the most prominent. CVD can be prevented if appropriate measures of screening and treatment of modifiable risk factors are addressed. This may translate to reduced risk of CVDs and some cancers in the long term. Increasing evidence exhibits common risk factors for both CVDs and cancer and that CVDs and their risk factors when present in cancer patients may worsen the overall outcome.
Objectives: The primary objective was to determine and compare the prevalence of hypertension, diabetes, obesity and dyslipidaemia amongst newly diagnosed cancer patients and non-cancer patients (elective surgical patients). Secondary objectives were to estimate and compare the 10yrs predicted occurrence of major cardiovascular events using WHO Afri-E risk score and prevalence of metabolic syndrome in the two populations.
Methodology: a Cross-sectional survey of newly diagnosed cancer patients and non-cancer patients in the same institution.
Results: The prevalence of hypertension was 23.4 and 31.58% in the cancer and non-cancer group respectively (p-value = 0.62). Diabetes was more prevalent in the cancer group, but this was not statistically different (7.89% vs. 1.32% with a P-value of 0.05). Obesity was more prevalent in the non-cancer group than the cancer group (58% vs. 54%), but this was not statistically significant (p- value = 0.85). The prevalence of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides were higher in the cancer group (76.3%) than the non-cancer group (67.1%), but this difference was not significant (p-value =0.21) .The prevalence of metabolic syndrome was similar in both groups with the cancer group having a prevalence of 30.26% and the non-cancer group 31.58% (p-value=0.86). The AFRI-E CV risk estimations were similar across the various risk stratifications (p-values ranging from 0.32 – 1)
Conclusion: There is no significant difference in prevalence of hypertension, diabetes, obesity, but there was a significant difference in the HDL levels (p=0.009), with the cancer group with lower HDL levels, amongst newly diagnosed cancer patients and non-cancer patients at AKUHN. Despite this the prevalence of CVR is appreciable and warrants screening. Similarly, the CV risk scores and prevalence of metabolic syndrome were not significantly different.